Shorepath Capital Management LLC grew its stake in Danaher Co. (NYSE:DHR - Free Report) by 16.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,497 shares of the conglomerate's stock after purchasing an additional 4,462 shares during the period. Danaher comprises approximately 5.2% of Shorepath Capital Management LLC's investment portfolio, making the stock its 9th largest holding. Shorepath Capital Management LLC's holdings in Danaher were worth $7,230,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in DHR. Teachers Insurance & Annuity Association of America purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $39,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Danaher in the third quarter valued at about $40,000. FSA Wealth Management LLC purchased a new stake in shares of Danaher during the third quarter worth about $50,000. Darwin Wealth Management LLC purchased a new position in Danaher in the 3rd quarter valued at about $55,000. Finally, Modus Advisors LLC acquired a new stake in Danaher in the 4th quarter worth about $56,000. Institutional investors and hedge funds own 79.05% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on DHR. KeyCorp upped their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research note on Wednesday, October 23rd. Stephens reiterated an "overweight" rating and set a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. TD Cowen upped their target price on Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Citigroup reduced their price target on Danaher from $305.00 to $285.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Finally, Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $286.80.
Check Out Our Latest Report on DHR
Danaher Stock Down 1.0 %
NYSE:DHR traded down $2.30 during trading hours on Tuesday, hitting $237.58. The company's stock had a trading volume of 4,137,586 shares, compared to its average volume of 3,079,633. Danaher Co. has a 52-week low of $222.53 and a 52-week high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $171.60 billion, a P/E ratio of 45.34, a price-to-earnings-growth ratio of 4.32 and a beta of 0.83. The stock has a fifty day moving average of $235.52 and a 200-day moving average of $253.65.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business's revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.02 EPS. On average, equities analysts forecast that Danaher Co. will post 7.5 earnings per share for the current year.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date is Friday, December 27th. Danaher's dividend payout ratio (DPR) is 20.61%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.